These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28876122)

  • 1. Activity of 3'-hydroxychalcone against Cryptococcus gattii and toxicity, and efficacy in alternative animal models.
    Palanco AC; Lacorte Singulani J; Costa-Orlandi CB; Gullo FP; Strohmayer Lourencetti NM; Gomes PC; Ayusso GM; Dutra LA; Silva Bolzani VD; Regasini LO; Soares Mendes-Giannini MJ; Fusco-Almeida AM
    Future Microbiol; 2017 Oct; 12():1123-1134. PubMed ID: 28876122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of voriconazole in vitro and in invertebrate model of cryptococcosis.
    de Castro Spadari C; da Silva de Bastiani FWM; Pisani PBB; de Azevedo Melo AS; Ishida K
    Arch Microbiol; 2020 May; 202(4):773-784. PubMed ID: 31832690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal activity of promethazine and chlorpromazine against planktonic cells and biofilms of Cryptococcus neoformans/Cryptococcus gattii complex species.
    Brilhante RSN; Gotay WJP; Pereira VS; de Oliveira JS; Pereira-Neto WA; Castelo-Branco DSCM; Cordeiro RA; Sidrim JJC; Rocha MFG
    Med Mycol; 2020 Oct; 58(7):906-912. PubMed ID: 32016364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal and antibiofilm effect of duloxetine hydrochloride against Cryptococcus neoformans and Cryptococcus gattii.
    Rehem AR; da Gama Viveiro LR; De Souza Santos EL; do Carmo PHF; da Silva NS; Junqueira JC; Scorzoni L
    Folia Microbiol (Praha); 2024 Dec; 69(6):1247-1254. PubMed ID: 38652436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Miltefosine Has a Postantifungal Effect and Induces Apoptosis in Cryptococcus Yeasts.
    Spadari CC; Vila T; Rozental S; Ishida K
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844051
    [No Abstract]   [Full Text] [Related]  

  • 6. Darunavir inhibits
    Brilhante RSN; Silva JAT; Araújo GDS; Pereira VS; Gotay WJP; Oliveira JS; Guedes GMM; Pereira-Neto WA; Castelo-Branco DSCM; Cordeiro RA; Sidrim JJC; Rocha MFG
    J Med Microbiol; 2020 Jun; 69(6):830-837. PubMed ID: 32459616
    [No Abstract]   [Full Text] [Related]  

  • 7. Control of
    Almeida-Apolonio AA; Cupozak-Pinheiro WJ; Berres VM; Dantas FGS; Svidzinski TIE; Oliveira KMP; Chang MR
    ScientificWorldJournal; 2018; 2018():5764187. PubMed ID: 29977170
    [No Abstract]   [Full Text] [Related]  

  • 8. Thiazole derivatives act on virulence factors of Cryptococcus spp.
    de Sá NP; de Barros PP; Junqueira JC; Vaz JA; de Oliveira RB; Rosa CA; Santos DA; Johann S
    Med Mycol; 2019 Jan; 57(1):84-91. PubMed ID: 29471408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A subdose of fluconazole alters the virulence of Cryptococcus gattii during murine cryptococcosis and modulates type I interferon expression.
    Fontes AC; Bretas Oliveira D; Santos JR; Carneiro HC; Ribeiro NQ; Oliveira LV; Barcellos VA; Paixão TA; Abrahão JS; Resende-Stoianoff MA; Vainstein MH; Santos DA
    Med Mycol; 2017 Feb; 55(2):203-212. PubMed ID: 27486215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifolates inhibit Cryptococcus biofilms and enhance susceptibility of planktonic cells to amphotericin B.
    de Aguiar Cordeiro R; Mourão CI; Rocha MF; de Farias Marques FJ; Teixeira CE; de Oliveira Miranda DF; Neto LV; Brilhante RS; de Jesus Pinheiro Gomes Bandeira T; Sidrim JJ
    Eur J Clin Microbiol Infect Dis; 2013 Apr; 32(4):557-64. PubMed ID: 23192488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astemizole and an analogue promote fungicidal activity of fluconazole against Cryptococcus neoformans var. grubii and Cryptococcus gattii.
    Vu K; Gelli A
    Med Mycol; 2010 Mar; 48(2):255-62. PubMed ID: 19572230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal Activity, Antibiofilm and Association Studies with O-Alkylamidoximes against Cryptococcus spp.
    de Castro Teixeira AP; Fernandes Queiroga Moraes G; de Oliveira RJ; Silva Santos C; Alves Caiana RR; Rufino de Freitas JC; Vasconcelos U; de Oliveira Pereira F; Oliveira Lima I
    Chem Biodivers; 2023 Mar; 20(3):e202200539. PubMed ID: 36730650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.
    Hagen F; Hare Jensen R; Meis JF; Arendrup MC
    Mycoses; 2016 Sep; 59(9):576-84. PubMed ID: 27061834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal susceptibility of clinical and environmental Cryptococcus neoformans and Cryptococcus gattii isolates in Jabalpur, a city of Madhya Pradesh in Central India.
    Gutch RS; Nawange SR; Singh SM; Yadu R; Tiwari A; Gumasta R; Kavishwar A
    Braz J Microbiol; 2015; 46(4):1125-33. PubMed ID: 26691471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal activity of eicosanoic acids isolated from the endophytic fungus Mycosphaerella sp. against Cryptococcus neoformans and C. gattii.
    Pereira CB; Pereira de Sá N; Borelli BM; Rosa CA; Barbeira PJS; Cota BB; Johann S
    Microb Pathog; 2016 Nov; 100():205-212. PubMed ID: 27693577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiazole compounds with activity against Cryptococcus gattii and Cryptococcus neoformans in vitro.
    Pereira de Sá N; Lino CI; Fonseca NC; Borelli BM; Ramos JP; Souza-Fagundes EM; Rosa CA; Santos DA; Barbosa de Oliveira R; Johann S
    Eur J Med Chem; 2015 Sep; 102():233-42. PubMed ID: 26276437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxyaldimines as potent in vitro anticryptococcal agents.
    Magalhães TF; da Silva CM; de Fátima Â; da Silva DL; Modolo LV; Martins CV; Alves RB; Ruiz AL; Longato GB; de Carvalho JE; de Resende-Stoianoff MA
    Lett Appl Microbiol; 2013 Aug; 57(2):137-43. PubMed ID: 23594040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory activity of isoniazid and ethionamide against Cryptococcus biofilms.
    Cordeiro Rde A; Serpa R; Marques FJ; de Melo CV; Evangelista AJ; Mota VF; Brilhante RS; Bandeira Tde J; Rocha MF; Sidrim JJ
    Can J Microbiol; 2015 Nov; 61(11):827-36. PubMed ID: 26362025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterisation and antifungal susceptibility of clinical Cryptococcus deuterogattii (AFLP6/VGII) isolates from Southern Brazil.
    Herkert PF; Hagen F; de Oliveira Salvador GL; Gomes RR; Ferreira MS; Vicente VA; Muro MD; Pinheiro RL; Meis JF; Queiroz-Telles F
    Eur J Clin Microbiol Infect Dis; 2016 Nov; 35(11):1803-1810. PubMed ID: 27477855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility testing of amphotericin B for Cryptococcus neoformans variety grubii AFLP1/VNI and Cryptococcus gattii AFLP6/VGII by CLSI and flow cytometry.
    Morales BP; Trilles L; Bertho ÁL; Junior IN; de Oliveira Rde V; Wanke B; Lazéra Mdos S
    Mycoses; 2015 May; 58(5):273-9. PubMed ID: 25756839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.